Krishna P. Bhat

Krishna P. Bhat, Ph.D., is an Associate Professor of Cancer Biology at Mayo Clinic in Phoenix, Arizona, where he also holds the position of Senior Associate Consultant II-Research in the Department of Research and the Department of Immunology. His research is centered on understanding the genetic, molecular, and immunological mechanisms of glioblastoma (GBM), a highly aggressive brain cancer.

Dr. Bhat's research interests are deeply rooted in the biology of glioma stem-like cells (GSCs), with a focus on their radiation resistance, transcriptional plasticity, and mesenchymal phenotype. He investigates how these properties contribute to tumor recurrence and treatment failure. His lab also explores the complex interactions between myeloid cells, cancer cells, and the central nervous system using single-cell multi-omics technologies to decipher the brain tumor microenvironment. A significant aspect of his work involves developing liquid biopsies for brain cancer by analyzing transcriptomic signatures from tumor-educated platelets and blood-derived cell-free DNA methylation patterns.

His recent publications reveal a strong trend towards translational neuro-oncology, combining molecular discovery with therapeutic development. Key research areas include mesenchymal differentiation, tumor microenvironment signaling (especially involving NF-κB, TAZ, and IL-8), therapy resistance mechanisms, and the application of advanced technologies like single-cell analysis and metabolomics for biomarker discovery.

Scientific Awards and Professional Memberships:

• Member, American Association for the Advancement of Science (2016–present)
• Member, editorial board, Neuro-Oncology (2015–present)
• Member, American Association for Cancer Research (2013–present)
• Interdisciplinary Translational Education and Research Training Outstanding Mentorship Award, University of Texas MD Anderson Cancer Center (2020)
• Excellence in Adult Basic Science Research Award, Society for Neuro-Oncology (2010)

Dr. Bhat has made significant contributions as a mentor and collaborator, co-authoring numerous studies with trainees and colleagues. His work is supported by institutional and collaborative research grants focused on cancer biology and neuro-oncology, though specific grant details are not provided in the source text.

His research is conducted within the framework of Mayo Clinic Comprehensive Cancer Center’s Cancer Biology Research program, specifically the Cancer Cell Genomics, Signalling, and Metastasis Program, leveraging core facilities and interdisciplinary teams for high-impact translational research.